Wednesday, July 16, 2025 | 01:06 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Covid-19 crisis: Hydroxychloroquine halted in WHO-funded trials

Trump has touted the antimalarial as a treatment for the coronavirus since the early weeks of the global outbreak, calling it a "game-changer," but its prospects have faded

hydroxychloroquine, hcq, drugs, coronavirus, pharma
premium

US Food and Drug Administration on Monday revoked emergency-use authorization for hydroxychloroquine and chloroquine, a related antimalarial drug, after determining they were unlikely to treat the virus and could have dangerous side effects.

Bloomberg
Tests of hydroxychloroquine, an anti-malaria drug touted by U.S. President Donald Trump, were halted in a World Health Organization trial of potential Covid-19 treatments.
 
The hydroxychloroquine arm of the WHO’s Solidarity trial was stopped after advisers concluded that the drug shows no benefit compared to the standard of care in reducing deaths, Ana Maria Henao-Restrepo, a WHO medical officer, said Wednesday at a briefing in Geneva.
 
Trump has touted the antimalarial as a treatment for the coronavirus since the early weeks of the global outbreak, calling it a “game-changer,” but its prospects have faded. US Food and Drug Administration on